About bioZhena – tech pitch
Women’s reproductive health in vivo diagnostics & informatics
How we’ll befriend one half (the better half) of humankind… We have solved the problem of fertile window determination – by monitoring folliculogenesis in vivo. In so doing, we have a handle on numerous aspects of women’s health. Read on to appreciate this.
In the slide on the right, below, is an example of real-life menstrual cyclic profiles (aka folliculogenesis profiles) generated with our personal home-use monitor by a subject of a small clinical study. The lower curve is the morning data while the profile with the higher signal amplitudes is the evening data. During the fertile window days (marked with the green on the time axis), the difference is practically indistinguishable, whereas outside of the fertile period of 3 days the signal invariably grows between the morning and evening hours (as the folliculogenesis process progresses with time). The BBT or Basal Body Temperature profile, shown in the lower part for comparison, was measured by the same woman in the usual manner. The various features of the menstrual cyclic profile are correlated with the various stages of the folliculogenesis process. This includes the dominant follicle maturation in the early pre-ovulation phase of the cycle, and the follicular waves in the pre-menstrual, post-ovulation, phase of the cycle. In the accompanying post script below, you can see the slide enlarged and animated.
The bioZhena venture involves electronic device technology developed to make it possible that every pregnancy is deliberate, and to impact on women’s healthcare and public health in other ways, too. (The latter because much in women’s health revolves around the menstrual cycle.)
Our ovulographic™ technology is the definitive answer to the basic need of women everywhere – natural and affordable reproductive management. Our personal self-diagnostic device, the Ovulona™, will tell the woman in plain English (or Spanish, German, Chinese, Arabic, etc.) whether today is one of the three days that she can become pregnant. Three or four day window, unless stress causes delayed ovulation or suppresses ovulation completely, either of which is then detected, too.
With cervical cancer screening automatically going on in the background; and with other uses (such as early pregnancy detection; data-based forecast of the EDD, Estimated Date of Delivery; management of PMS/PMDD; management of hormone therapy, to mention a few… and not to mention fetal sex pre-selection!).
The Ovulona device-stored longitudinal data can be optionally provided to the woman’s physician(s) and the healthcare system – a novel way of patient profiling. A telemedicine tool.
This is not another ovulation kit only for those who find it difficult to become pregnant, and we position the Ovulona to be a product that practically every woman will want to use. The woman of the 21st Century is envisaged to become accustomed to using her daily Ovulona self-check about as routinely as she is using her toothbrush.
bioZhena Corporation seeks financing with which to manufacture our first batch of the first marketable product within 7 months, the first milestone towards envisaged market dominance in scientific family planning™. The prototype for the use as a conceptive aid (as opposed to the birth control use and the cervical cancer screen) has already been FDA-certified.
Introducing the folliculogenesis (menstrual cycling) pattern as generated by the Ovulona device from bioZhena Corporation
The purpose of this post script is to give the interested reader a chance to see better the data shown and discussed in the introduction above. The slides are best viewed in the Slide Show mode because there is some meaningful animation and the size favors legibility of details.
biozhena-corp-single-slide-3-day-window
If interested further, then I suggest the next short set of slides, which reiterates and builds on the first – still merely whetting your appetite.
For, if you do have appetite for this sort of thing, then you will like the aberrant cycle and its interpretation – for the implication therein for the diagnostic power of this simple-to-use diagnostic tool made to be used by women at home, and optionally by their physicians when the medical help is sought.
bioZhena Corporation and our core technology
In case of serious interest in bioZhena, I refer you to the introductory documents that we reference as package #1. After that, if interested further, you would need to execute the confidentiality agreement that you would ask for by emailing me at vaclavkirsner@yahoo.com .
Here is package 1 (two of the pieces are 1-pagers, while the third is a bit longer because it is illustrated, in the effort to help you grasp what we are about – to help you get the big picture).
